Eton Pharmaceutcials Inc (ETON) returns
Eton Pharmaceutcials returns over 5 years
$1,000 invested in Eton Pharmaceutcials five years ago was worth $9,059 at the close on October 30, 2026, with dividends reinvested: an average return of 55.4% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +1.3% | — | $1,013 | -0.9% |
| 3 months | +6.4% | — | $1,064 | +2.1% |
| Year to date | +208.6% | — | $3,086 | +11.7% |
| 1 year | +185.9% | — | $2,859 | +12.4% |
| 3 years | +1,235% | +137.2% | $13,345 | +88.5% |
| 5 years | +805.9% | +55.4% | $9,059 | +76.0% |
Eton Pharmaceutcials return by calendar year
| Year | ETON | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +208.6% | +11.7% | +196.9% |
| 2025 | +27.0% | +17.7% | +9.2% |
| 2024 | +204.1% | +24.9% | +179.2% |
| 2023 | +55.3% | +26.2% | +29.1% |
| 2022 | -34.3% | -18.2% | -16.1% |
| 2021 | -47.2% | +28.7% | -76.0% |
| 2020 | +12.9% | +18.4% | -5.5% |
| 2019 | +17.6% | +31.2% | -13.6% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: ETON financials · ETON valuation
No forecast, no recommendation. This page describes Eton Pharmaceutcials Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.